Compressed antisolvent process for polymer coating of drug-loaded aerogel nanoparticles and study of the release behavior

The overall objective of the present work was to modulate the release behavior of drug-impregnated silica particles from almost instantaneous release to a more sustained delivery, prolonged during several hours. Triflusal was chosen as a model drug of the low biodisponibility type. The process is based in the coating with Eudragit® RL 100 polymer of aerogel-like silica particles. Materials were processed in compressed CO₂ by using the batch and semicontinuous antisolvent coating methods. Triflusal release from Eudragit-coated aerogel particles was compared with the dissolution profiles recorded for pristine triflusal and for triflusal impregnated into polymer or non-coated aerogel particles. The release profiles were determined by high-performance liquid chromatography. Eudragit-coated materials presented an intermediate drug-release rate between this obtained for the infused polymer and that of the impregnated aerogel particles. Diffusion-governed mechanisms were found for the studied aerogel-like systems after fitting the release data to both Korsmeyer-Peppas and Baker-Lonsdale equations. The major advantage of the compressed CO₂ antisolvent approach was the ability to physically coat very fine particles (<100 nm). Moreover, the stability of the studied drug in water increased after coating. Figure

Schematic representation of the antisolvent CO₂ particle coating and release behavior of the obtained hybrid products